Cargando…
Advances in quantitative methods and modeling for complex generic drugs and opportunities to hybridize learnings between innovator and generic drug developers
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196422/ https://www.ncbi.nlm.nih.gov/pubmed/37113050 http://dx.doi.org/10.1002/psp4.12968 |
| _version_ | 1785044350435065856 |
|---|---|
| author | Jayachandran, Priya |
| author_facet | Jayachandran, Priya |
| author_sort | Jayachandran, Priya |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10196422 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101964222023-05-20 Advances in quantitative methods and modeling for complex generic drugs and opportunities to hybridize learnings between innovator and generic drug developers Jayachandran, Priya CPT Pharmacometrics Syst Pharmacol Perspectives John Wiley and Sons Inc. 2023-04-27 /pmc/articles/PMC10196422/ /pubmed/37113050 http://dx.doi.org/10.1002/psp4.12968 Text en © 2023 The Author. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals LLC on behalf of the American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Perspectives Jayachandran, Priya Advances in quantitative methods and modeling for complex generic drugs and opportunities to hybridize learnings between innovator and generic drug developers |
| title | Advances in quantitative methods and modeling for complex generic drugs and opportunities to hybridize learnings between innovator and generic drug developers |
| title_full | Advances in quantitative methods and modeling for complex generic drugs and opportunities to hybridize learnings between innovator and generic drug developers |
| title_fullStr | Advances in quantitative methods and modeling for complex generic drugs and opportunities to hybridize learnings between innovator and generic drug developers |
| title_full_unstemmed | Advances in quantitative methods and modeling for complex generic drugs and opportunities to hybridize learnings between innovator and generic drug developers |
| title_short | Advances in quantitative methods and modeling for complex generic drugs and opportunities to hybridize learnings between innovator and generic drug developers |
| title_sort | advances in quantitative methods and modeling for complex generic drugs and opportunities to hybridize learnings between innovator and generic drug developers |
| topic | Perspectives |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196422/ https://www.ncbi.nlm.nih.gov/pubmed/37113050 http://dx.doi.org/10.1002/psp4.12968 |
| work_keys_str_mv | AT jayachandranpriya advancesinquantitativemethodsandmodelingforcomplexgenericdrugsandopportunitiestohybridizelearningsbetweeninnovatorandgenericdrugdevelopers |